Adaptation and implementation of health Qigong and Tai Chi exercises on quality of life and physical functioning in patients with atrial fibrillation: a feasibility study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN16703816

Enrollment

106

Registered

2022-03-25

Start date

2022-01-18

Completion date

Unknown

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tai Chi and Qigong for patients with atrial fibrillation. Circulatory System

Interventions

Current intervention as of 27/12/2023: Approximately 106 participants will be recruited from primary care. The study took place online via the virtual platform (Zoom). The participants were randomly a

and 10 participants from the intervention group for the embedded qualitative study. Participants in the control group will receive usual care for the management of atrial fibrillation, consisting of

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnosis of AF. 2. Able to understand spoken English. 3. Able to provide written informed consent. 4. Adults aged =18 years old. 5. If social distancing due to COVID-19 persists: the participants should have internet access at home and download free Zoom software onto a computer, mobile phone, or any electronic tablet or TV for delivery of the exercise intervention.

Exclusion criteria

Exclusion criteria: 1. Pre-existing medical condition preventing safe exercising (i.e., inability to stand unaided).

Design outcomes

Primary

Measure	Time frame
Recruitment rate and retention rate at baseline, during 12 weeks of the intervention: 1. Recruitment rate: the number of the returned consent-to-contact forms will be calculated from the total number of invitations sent to eligible patients (response rate). The total number of those who will attend the intervention will be counted and will be divided by the number of invitations sent. 2. Retention rate: the number of sessions that participants attend over the 12 weeks will be collected and whether they complete the whole session each time or not. 100% attendance will be recorded as a minimum of one session per week for 12 weeks.	—

Measure

Time frame

Recruitment rate and retention rate at baseline, during 12 weeks of the intervention: 1. Recruitment rate: the number of the returned consent-to-contact forms will be calculated from the total number of invitations sent to eligible patients (response rate). The total number of those who will attend the intervention will be counted and will be divided by the number of invitations sent. 2. Retention rate: the number of sessions that participants attend over the 12 weeks will be collected and whether they complete the whole session each time or not. 100% attendance will be recorded as a minimum of one session per week for 12 weeks.

—

Secondary

Measure	Time frame
Current secondary outcome measures as of 27/12/2023: 1. Health-related quality of life and physical functioning assessed using the Short Form 12-item questionnaire (SF-12), Atrial Fibrillation Effect on Quality-of-life (AFEQT) Questionnaire, and the EuroQol questionnaire (EQ-5D) at baseline, 6 and 12 weeks 2. Patient satisfaction with the intervention was measured using a researcher-developed questionnaire at 12 weeks _____ Previous secondary outcome measures: 1. Health-related quality of life will be assessed using the Short Form 12-item questionnaire (SF-12), Atrial Fibrillation Effect on Quality-of-life (AFEQT) Questionnaire, and the EuroQol questionnaire (EQ-5D), at baseline, 6 and 12 weeks 2. Physical functioning will be measured by the 6-minute walk test (6MWT), at baseline, 6 and 12 weeks 3. Balance, gait and mobility will be measured by The Short Physical Performance Battery test (SPPB), at baseline, 6 and 12 weeks 4. Patient satisfaction with the intervention will be measured using a researcher-developed questionnaire, at 12 weeks	—

Measure

Time frame

Current secondary outcome measures as of 27/12/2023: 1. Health-related quality of life and physical functioning assessed using the Short Form 12-item questionnaire (SF-12), Atrial Fibrillation Effect on Quality-of-life (AFEQT) Questionnaire, and the EuroQol questionnaire (EQ-5D) at baseline, 6 and 12 weeks 2. Patient satisfaction with the intervention was measured using a researcher-developed questionnaire at 12 weeks _____ Previous secondary outcome measures: 1. Health-related quality of life will be assessed using the Short Form 12-item questionnaire (SF-12), Atrial Fibrillation Effect on Quality-of-life (AFEQT) Questionnaire, and the EuroQol questionnaire (EQ-5D), at baseline, 6 and 12 weeks 2. Physical functioning will be measured by the 6-minute walk test (6MWT), at baseline, 6 and 12 weeks 3. Balance, gait and mobility will be measured by The Short Physical Performance Battery test (SPPB), at baseline, 6 and 12 weeks 4. Patient satisfaction with the intervention will be measured using a researcher-developed questionnaire, at 12 weeks

—

Countries

England, United Kingdom, Wales

Contacts

Public ContactAhlam Abu Elkhair

ahlam244@liverpool.ac.uk+44 7424101981

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026